Hu et al. identify ROCK2 in liver sinusoidal endothelial cells as a key factor in liver fibrosis. Through single-cell analysis, knockout models, protein studies, and early clinical research, the authors show that ROCK2-driven endothelial cytoskeletal changes trigger angiocrine signals that activate hepatic stellate cells—highlighting a potential therapeutic target.